Literature DB >> 18341338

On-virus construction of polyvalent glycan ligands for cell-surface receptors.

Eiton Kaltgrad1, Mary K O'Reilly, Liang Liao, Shoufa Han, James C Paulson, M G Finn.   

Abstract

Glycans arrayed on the exterior of virus particles were used as substrates for glycosyltransferase reactions to build di- and trisaccharides from the virus surface. The resulting particles exhibited tight and specific associations with cognate receptors on beads and cells, in one example defeating in cis cell-surface interactions in a manner characteristic of polyvalent binding. Combined with the ability of viruses to provide structurally well-defined attachment points, the methodology provides a convenient and powerful way to prepare complex carbohydrate ligands for clustered receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18341338      PMCID: PMC5469293          DOI: 10.1021/ja077801n

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  24 in total

Review 1.  The cluster glycoside effect.

Authors:  Joseph J Lundquist; Eric J Toone
Journal:  Chem Rev       Date:  2002-02       Impact factor: 60.622

Review 2.  Cell surface biology mediated by low affinity multivalent protein-glycan interactions.

Authors:  Brian E Collins; James C Paulson
Journal:  Curr Opin Chem Biol       Date:  2004-12       Impact factor: 8.822

3.  Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold.

Authors:  Sayam Sen Gupta; Jane Kuzelka; Pratik Singh; Warren G Lewis; Marianne Manchester; M G Finn
Journal:  Bioconjug Chem       Date:  2005 Nov-Dec       Impact factor: 4.774

4.  Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides.

Authors:  Ola Blixt; Kirk Allin; Laura Pereira; Arun Datta; James C Paulson
Journal:  J Am Chem Soc       Date:  2002-05-22       Impact factor: 15.419

5.  Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking.

Authors:  Shoufa Han; Brian E Collins; Per Bengtson; James C Paulson
Journal:  Nat Chem Biol       Date:  2005-06-12       Impact factor: 15.040

6.  Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.

Authors:  Ella Kagan; Govind Ragupathi; San San Yi; Celso A Reis; Jeff Gildersleeve; Daniel Kahne; Henrik Clausen; Samuel J Danishefsky; Philip O Livingston
Journal:  Cancer Immunol Immunother       Date:  2004-12-30       Impact factor: 6.968

7.  Efficient preparation of natural and synthetic galactosides with a recombinant beta-1,4-galactosyltransferase-/UDP-4'-gal epimerase fusion protein.

Authors:  O Blixt; J Brown; M J Schur; W Wakarchuk; J C Paulson
Journal:  J Org Chem       Date:  2001-04-06       Impact factor: 4.354

8.  Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin.

Authors:  Nathan R Zaccai; Katsumi Maenaka; Taeko Maenaka; Paul R Crocker; Reinhard Brossmer; Sørge Kelm; E Yvonne Jones
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

9.  Natural supramolecular building blocks. Wild-type cowpea mosaic virus.

Authors:  Qian Wang; Eiton Kaltgrad; Tianwei Lin; John E Johnson; M G Finn
Journal:  Chem Biol       Date:  2002-07

Review 10.  Chemical biology of the sugar code.

Authors:  Hans-Joachim Gabius; Hans-Christian Siebert; Sabine André; Jesús Jiménez-Barbero; Harold Rüdiger
Journal:  Chembiochem       Date:  2004-06-07       Impact factor: 3.164

View more
  27 in total

1.  CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.

Authors:  Mary K O'Reilly; Hua Tian; James C Paulson
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

2.  A potential nanobiotechnology platform based on infectious bursal disease subviral particles.

Authors:  Omid Taghavian; Manoj K Mandal; Nicole F Steinmetz; Stefan Rasche; Holger Spiegel; Rainer Fischer; Stefan Schillberg
Journal:  RSC Adv       Date:  2012-01-09       Impact factor: 3.361

3.  Adenovirus in a synthetic membrane wrapper: an example of hybrid vigor?

Authors:  David H Thompson
Journal:  ACS Nano       Date:  2008-05       Impact factor: 15.881

4.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

5.  Multivalent ligands for siglecs.

Authors:  Mary K O'Reilly; James C Paulson
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

6.  Glycan-targeted virus-like nanoparticles for photodynamic therapy.

Authors:  Jin-Kyu Rhee; Michael Baksh; Corwin Nycholat; James C Paulson; Hiroaki Kitagishi; M G Finn
Journal:  Biomacromolecules       Date:  2012-07-24       Impact factor: 6.988

7.  Click and pick: identification of sialoside analogues for siglec-based cell targeting.

Authors:  Cory D Rillahan; Erik Schwartz; Ryan McBride; Valery V Fokin; James C Paulson
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-04       Impact factor: 15.336

8.  Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties.

Authors:  Lars O Liepold; Md Joynal Abedin; Emily D Buckhouse; Joseph A Frank; Mark J Young; Trevor Douglas
Journal:  Nano Lett       Date:  2009-12       Impact factor: 11.189

9.  Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation.

Authors:  Vu Hong; Stanislav I Presolski; Celia Ma; M G Finn
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 10.  Siglecs as targets for therapy in immune-cell-mediated disease.

Authors:  Mary K O'Reilly; James C Paulson
Journal:  Trends Pharmacol Sci       Date:  2009-04-07       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.